IRIDEX Corporation (IRIX)
NASDAQ$1.13
Market Cap
$18.8M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
652 of 924
Rank in Industry
81 of 118
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
IRIX Insider Trading Activity
IRIX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
No records found
About IRIDEX Corporation
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems …
Insider Activity of IRIDEX Corporation
Over the last 12 months, insiders at IRIDEX Corporation have bought $0 and sold $0 worth of IRIDEX Corporation stock.
On average, over the past 5 years, insiders at IRIDEX Corporation have bought $19,258 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,000 shares for transaction amount of $6,200 was made by Devi Nandini () on 2022‑05‑20.
List of Insider Buy and Sell Transactions, IRIDEX Corporation
| 2022-05-20 | Devi Nandini | 2,000 0.0126% | $3.10 | $6,200 | -24.68% | |||
| 2022-03-16 | Devi Nandini | 2,000 0.0122% | $4.20 | $8,400 | -41.86% | |||
| 2021-12-02 | Grove Robert Earle | director | 1,644 0.0102% | $6.08 | $9,999 | -49.59% | ||
| 2021-11-16 | Devi Nandini | director | 1,000 0.0064% | $7.73 | $7,730 | -56.27% | ||
| 2020-05-15 | Grove Robert Earle | director | 15,125 0.1082% | $1.68 | $25,446 | +44.22% | ||
| 2019-11-18 | Grove Robert Earle | director | 14,600 0.0911% | $2.04 | $29,749 | +0.49% | ||
| 2019-11-15 | Grove Robert Earle | director | 10,000 0.0625% | $2.02 | $20,187 | +1.49% | ||
| 2019-11-14 | Shuda Scott | director | 10,000 0.0625% | $2.02 | $20,200 | +1.49% | ||
| 2019-11-13 | Shuda Scott | director | 5,000 0.0311% | $2.01 | $10,050 | +1.49% | ||
| 2018-12-13 | Grove Robert Earle | director | 863 0.0054% | $4.30 | $3,711 | -0.82% | ||
| 2018-12-12 | MOORE WILLIAM M | Chairman and CEO | 10,000 0.0642% | $4.34 | $43,443 | +0.59% | ||
| 2018-12-12 | Grove Robert Earle | director | 3,684 0.0235% | $4.32 | $15,903 | +0.59% | ||
| 2018-12-11 | Grove Robert Earle | director | 4,673 0.0298% | $4.18 | $19,542 | +3.78% | ||
| 2018-12-10 | Grove Robert Earle | director | 2,500 0.0156% | $4.17 | $10,432 | +1.55% | ||
| 2018-11-27 | MOORE WILLIAM M | Chairman and CEO | 10,000 0.062% | $4.71 | $47,144 | -8.11% | ||
| 2018-09-18 | PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 70,000 0.4375% | $6.00 | $420,000 | -22.00% | |||
| 2018-09-14 | MOORE WILLIAM M | Chairman and CEO | 10,000 0.0613% | $6.56 | $65,600 | -29.97% | ||
| 2018-03-13 | Sale | Dizon Romeo R | 2,806 0.0166% | $5.86 | $16,444 | -6.77% | ||
| 2017-12-12 | MOORE WILLIAM M | Chairman and CEO | 5,000 0.0318% | $7.84 | $39,200 | -15.82% | ||
| 2017-09-15 | MOORE WILLIAM M | Chairman and CEO | 1,800 0.0109% | $9.42 | $16,956 | -23.20% |
Total: 288
Insider Historical Profitability
5.94%
| BlueLine Catalyst Fund IX, L.P. | 2559122 15.3827% | $2.89M | 18 | 0 | +10.82% | |
| BlueLine Capital Partners II, L.P. | 10 percent owner | 2508100 15.076% | $2.83M | 2 | 0 | +27.27% |
| BlueLine Partners, L.L.C. | 10 percent owner | 2465222 14.8182% | $2.79M | 9 | 0 | |
| Acuta Capital Fund, LP | 10 percent owner | 1344720 8.083% | $1.52M | 33 | 0 | <0.0001% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 1320000 7.9344% | $1.49M | 17 | 0 | +39.25% |
IRIX Institutional Investors: Active Positions
| Increased Positions | 5 | +13.51% | 31,328 | +0.94% |
| Decreased Positions | 13 | -35.14% | 132,198 | -3.97% |
| New Positions | <1 | New | 12,979 | New |
| Sold Out Positions | 2 | Sold Out | 2,000 | Sold Out |
| Total Postitions | 29 | -21.62% | 3M | -3.03% |
IRIX Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Paragon Associates & Paragon Associates Ii Joint Venture | $1,380.00 | 5.88% | 1M | 0 | 0% | 2024-12-31 |
| Vanguard Group Inc | $774.00 | 3.3% | 561,096 | 0 | 0% | 2024-12-31 |
| Amh Equity Ltd | $692.00 | 2.95% | 501,121 | 0 | 0% | 2024-12-31 |
| Renaissance Technologies Llc | $526.00 | 2.24% | 381,160 | -16,200 | -4.08% | 2024-12-31 |
| Geode Capital Management, Llc | $181.00 | 0.77% | 131,172 | 0 | 0% | 2024-12-31 |
| Ars Investment Partners, Llc | $152.00 | 0.65% | 110,060 | -3,505 | -3.09% | 2024-12-31 |
| Bridgeway Capital Management, Llc | $97.00 | 0.41% | 70,000 | -6,975 | -9.06% | 2024-12-31 |
| Citadel Advisors Llc | $93.00 | 0.4% | 67,653 | +17,377 | +34.56% | 2024-12-31 |
| Apexium Financial, Lp | $91.00 | 0.39% | 65,695 | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $79.00 | 0.34% | 57,364 | +232 | +0.41% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.